International Journal of Thermofluids (May 2024)
Modeling analysis of pulsatile non-Newtonian blood flow in a renal bifurcated artery with stenosis
Abstract
A transient transport flow model is adopted in a renal bifurcated artery with different stenosis cases to examine the flow phenomena when the non-Newtonian blood flow regime within the three-dimensional space domain is chosen as a pulsatile nature. The nonlinear governing equations are solved using the Finite Element Method with suitable initial-boundary conditions. During numerical computation, distinct hemodynamic parameters including Wall shear stress, Reynolds number, power law index are evaluated based on different stenosis severities (0%, 25%, and 50%) and stenosis lengths (0mm, 0.5mm, and 1mm). For 0%, 25%, and 50% stenosis, the approximate values of velocity and pressure profiles are estimated at t = 5s at various positions, and achieved the highest velocities that were around 0.07m/s, 0.08m/s, and 0.13m/s respectively. The unsteady response of the stress due to stenosis-induced shear on the outside wall is described as a result of stenosis at t = 0.1s, 0.2s, 5s. The flow is severely restricted by constriction, which increases wall movement and produces stress, depending on the amount of stenosis. As pulsatile flow time increases due to the presence of stenosis, the wall shear stress decreases gradually. The impact of Reynolds numbers on pressure profiles and velocity profiles are displayed for Re = 100, 300, 500, and 700, and found that both velocity and pressure outlines increase significantly. In order to identify the flow phenomena, the influences of the power law index for n = 0.1, 0.3568, 0.5 are presented on the velocity and pressure profiles. Shear-thinning flow occurs for 0<n<1, pseudoplastic flow occurs for n = 0.1 and Bingham plastic flow occurs for n = 0.5. The modeling investigations of blood flow via arteries could assist in the diagnosis and treatment of arterial illnesses; as well as expand the knowledge about cardiovascular physiology and lead the development of revolutionary medical interventions to enhance patient treatment outcomes.
